Billions of dollars have been invested in researching and developing over 200 COVID-19 vaccine candidates, more than a dozen of which have been approved for use in at least one country.
Our team is compiling and analyzing publicly available data to better understand the public and private funding that supported the development of these vaccines, how production capacity is scaling up, and which countries are gaining access to vaccines.
You can view our analysis and download our datasets here:
COVID-19 Vaccine Access: Tracking purchases and donations of vaccines worldwide and disparities in access (updated biweekly)
COVID-19 Vaccine Manufacturing: Tracking arrangements between vaccine developers and manufacturers (updated biweekly)
COVID-19 Vaccine R&D Funding: Tracking investments into vaccine development (updated as new data becomes available)
We have also compiled a list of external open data sources that are relevant to research and development, intellectual property, and pricing of COVID-19 countermeasures: COVID-19 Data Resources.
Stay up to date!
Join our mailing list to be notified when we post substantive new research and analysis.